The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInter. Pers. Regulatory News (IPF)

Share Price Information for Inter. Pers. (IPF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.00
Bid: 104.50
Ask: 105.00
Change: -1.00 (-0.94%)
Spread: 0.50 (0.478%)
Open: 106.00
High: 106.00
Low: 105.00
Prev. Close: 106.00
IPF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q1 2021 Trading Update and board change

29 Apr 2021 07:00

RNS Number : 9858W
International Personal Finance Plc
29 April 2021

This announcement contains inside information

International Personal Finance

Q1 2021 trading update and board change

29 April 2021

International Personal Finance plc specialises in providing unsecured consumer credit to 1.7 million customers across 11 markets. We operate the world's largest home credit business and a successful fintech business.

Highlights

Robust Q1 trading performance delivered as we rebuild the business

Good progress in credit issued with YoY contraction moderating to 18% in Q1 2021 compared to 31% in Q4 2020

Continued strong collections performance in Q1 translated into a 5.2ppts reduction in Group annualised impairment as a percentage of revenue to 32.2%

Strong balance sheet to fund growth with headroom on undrawn facilities and non-operational cash balances of 拢175 million

Lower projected full year impairment charge likely to result in a stronger rebound in profitability than previously expected

Gerard Ryan, Chief Executive Officer at IPF commented:

"Our Group delivered a robust trading performance in the first quarter of the year with improved credit issued trends and a strong collections performance. We are selectively relaxing our credit settings and rebuilding our receivables portfolio, whilst maintaining credit quality and cost efficiency, to return strongly to full-year profitability. With the full extent of Covid yet to be determined, we know now more than ever that our business plays an essential role in society, providing finance responsibly to underbanked and underserved consumers and, in turn, delivering long-term growth and value to all our stakeholders."

Group Q1 overview

We are pleased to report that the Group continued to effectively execute its strategy to rebuild the business and return to full-year profitability and long-term growth. Building on the momentum achieved in the second half of 2020, we delivered a robust trading performance in the first quarter of the year despite the challenging operational landscape caused by the ongoing Covid-19 pandemic. Protecting our people and customers remains our top priority and we continue to provide personal protective equipment and appropriate training to all of our colleagues, and we have maintained a range of remote alternative repayment options if agents are unable to visit their customers.

Group collections performance remained strong throughout the quarter, enabling our selective relaxation of credit settings to continue. Our increasing sales momentum resulted in the YoY contraction of credit issued moderating from 31% in Q4 2020 to 18% in Q1 2021. Wave three of the pandemic across Europe is clearly supressing consumer demand for credit and we saw the impacts of this around the Easter period when Covid-19 infection rates were increasing significantly. We expect this impact to be temporary as vaccination rates are now increasing rapidly, and we plan to further increase credit issued and grow our receivables portfolio as related Covid restrictions are lifted.

Our business plan assumed a weakening in collections performance arising from subsequent waves of the pandemic in the first half of 2021. Against this backdrop, we are very pleased that our teams continued to deliver a very strong performance, resulting in a faster than anticipated improvement in impairment as a percentage of revenue, with the annualised rate reducing by 5.2ppts to 32.2% in Q1. We expect impairment to further improve during 2021 as the business continues to recover from the impact of the pandemic. We are also seeing the benefits of strong cost control and the significant cost-saving and rightsizing programmes implemented in 2020 to reflect the smaller scale of our operations and to accelerate a return to full-year profitability.

Business division performance review

As highlighted at the 2020 year end, we merged our two digital businesses in Poland in order to deliver efficiencies of scale and, as a result, the digital lending arm previously reported as part of European home credit is now included in IPF Digital. All comparatives have been amended accordingly and are presented on a like-for-like basis.

European home credit

European home credit delivered an improving performance against the challenging trading backdrop of dramatically rising Covid-19 cases and increasing restrictions of freedom of movement. Our strategy of carefully easing credit settings and rebuilding the receivables portfolio resulted in a significant improvement in sales momentum, with credit issued being flat YoY in Q1 compared to a contraction in Q4 2020 of 22%. Our collections remained strong during the first quarter despite planning for some softening in performance and, as a result, annualised impairment as a percentage of revenue improved 5.4 ppts since the year end to 31.0%.

Mexico home credit

Q1 credit issued in Mexico home credit contracted YoY by 23% which compares to a contraction in Q4 2020 of 26%, despite significant continued Covid-19 challenges. The benefits of actions taken to improve collections and credit quality in Mexico over the past 18 months continued to flow through the business and resulted in annualised impairment as a percentage of revenue improving by 5.4ppts to 28.3% in Q1 2021. This ratio is now within our target range for the Group of 25% to 30% for the first time in a number of years.

IPF Digital

IPF Digital had a more challenging quarter as Covid-19 related lockdowns, particularly in the Baltic states, impacted demand for consumer credit. This relatively soft demand, our continued cautious credit settings in Spain and the cessation of lending in Finland, resulted in a 49% contraction of credit issued YoY in Q1, compared to 54% in Q4 2020. Excluding Finland, where the portfolio collect-out is progressing well, credit issued contracted by 37%. Our collections performance continued to be strong, driven by higher-quality lending and robust processes, and this resulted in a 4.1ppt improvement in annualised impairment as a percentage of revenue to 41.3% in Q1.

Funding and balance sheet

We have a strong balance sheet to fund growth and at 30 March 2021 we had headroom on undrawn facilities and non-operational cash balances of 拢175 million.

Board change

After eleven years with IPF, the last four as Chief Financial Officer, Justin Lockwood will leave the Group at the end of July to take up a role in a different industry sector. Justin has made an outstanding contribution to our business, and he leaves with our heartfelt appreciation and best wishes for his future success. A search for a successor is now underway.

Outlook

Our business plays an essential role in society, providing credit responsibly to those who are underbanked or underserved, and there remains significant long-term demand for affordable credit from this group of consumers in all our markets. Our strategy remains to continue to carefully increase credit issued and rebuild the receivables portfolio while maintaining a clear focus on portfolio quality. Whilst credit issued was in-line with expectations in Q1, we remain cautious because of the dynamic Covid-19 environment and resulting frequent changes in lockdown restrictions which impact short-term demand for consumer credit.

Notwithstanding this challenge, the faster than anticipated improvement in impairment in Q1 is expected to result in a lower full-year impairment charge and a stronger rebound in profitability in 2021 than originally planned.

Investor and analyst conference call

International Personal Finance will host a conference call for investors and analysts at 09.00hrs (BST) today, Thursday 29 April 2021.

Click to Join

Simply click the link below and enter your information to be connected. The link becomes active 15 minutes prior to the start of the call. Click here to connect

Dial-in

If you prefer to dial-in, please use the access number and confirmation code below. Please dial-in 5-10 minutes before the start of the call.

Dial-in (UK)

+44 (0)330 336 9105

Confirmation code: 7301816

Replay:

An audio recording of the conference call will be available in the investors section of our website at www.ipfin.co.uk

Investor relations and media contact:

International Personal Finance

Rachel Moran

+44 (0)7760 167637 / +44 (0) 113 539 5466

A copy of this statement can be found on our website - www.ipfin.co.uk

Legal Entity Identifier: 213800II1O44IRKUZB59

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTMZGZDLRGGMZM
Date   Source Headline
8th Apr 20241:13 pmRNSDirector/PDMR Shareholding
5th Apr 202410:00 amRNSDirector/PDMR Shareholding
4th Apr 202410:48 amRNSDirector/PDMR Shareholding
3rd Apr 20243:29 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
27th Mar 20245:09 pmRNSDirector/PDMR Shareholding
25th Mar 20244:44 pmRNSAnnual Financial Report and Notice of AGM
21st Mar 20245:09 pmRNSDirector/PDMR Shareholding
19th Mar 20243:56 pmRNSDirector/PDMR Shareholding
18th Mar 20244:11 pmRNSDirector/PDMR Shareholding
15th Mar 202410:38 amRNSFinal Dividend Timetable Correction
14th Mar 20247:00 amRNSFinal Results and Accounts
26th Feb 20247:00 amRNSDelay of year-end results announcement
8th Feb 20247:00 amRNSDirector/PDMR Shareholding
27th Dec 20239:08 amRNSHolding(s) in Company
14th Dec 202311:24 amRNSPublication of Final Terms
24th Nov 20237:02 amRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSFinal Confirmation & Results of Exchange Offer
17th Nov 20233:18 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSAppointment of Joint Broker
14th Nov 20233:09 pmRNSHolding(s) in Company
8th Nov 20237:00 amRNSNotice of Investor Webinar - 7 December 2023
3rd Nov 20234:14 pmRNSIssuance and amendment to Final Terms
2nd Nov 20231:29 pmRNSCash Offer Launch
2nd Nov 20231:18 pmRNSExchange Offer
2nd Nov 20231:16 pmRNSPublication of a Prospectus
26th Oct 20237:01 amRNSRoadshow Announcement
26th Oct 20237:00 amRNSQ3 2023 Trading Update
25th Oct 20232:12 pmRNSChange of Senior Independent Director
24th Oct 20233:19 pmRNSPublication of Final Terms - Replacement Notice
24th Oct 20237:00 amRNSPublication of Final Terms
20th Oct 20237:00 amRNSUpdate on Annual General Meeting 2023 Vote
2nd Oct 20237:00 amRNSTotal Voting Rights
14th Sep 20231:46 pmRNSDirector/PDMR Shareholding
1st Sep 20237:00 amRNSTotal Voting Rights
24th Aug 20234:35 pmRNSPublication of a Prospectus
1st Aug 20237:00 amRNSHalf-year Report
13th Jul 202311:14 amRNSHolding(s) in Company
3rd Jul 20232:30 pmRNSTotal Voting Rights
3rd Jul 20239:20 amRNSBlock listing Interim Review
1st Jun 20237:00 amRNSTotal Voting Rights
11th May 20234:48 pmRNSDirector/PDMR Shareholding
4th May 202311:17 amRNSDirector/PDMR Shareholding
2nd May 202312:28 pmRNSTotal Voting Rights
27th Apr 20234:27 pmRNSResult of AGM
27th Apr 20237:00 amRNSQ1 2023 Trading Update
19th Apr 20234:44 pmRNSNotice of Investor Briefing - 10 May 2023
6th Apr 20232:54 pmRNSDirector/PDMR Shareholding
4th Apr 20234:42 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:37 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.